PMDA
- Application: Skyrizi
- Local brand name: Skyrizi
- Status: approved
🇯🇵 risankizumab SC in Japan
risankizumab SC (risankizumab SC) regulatory status in Japan.
Marketing authorisation
risankizumab SC in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Japan
Frequently asked questions
Is risankizumab SC approved in Japan?
Yes. PMDA has authorised it.
Who is the marketing authorisation holder for risankizumab SC in Japan?
AbbVie is the originator. The local marketing authorisation holder may differ — check the official source linked above.